-
Taxonomy & unit
-
us-gaap: CAD
-
Description
-
Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.
-
Summary
-
Evome Medical Technologies Inc. annual/quarterly Deferred Income Tax Expense (Benefit) history and growth rate from Q2 2021 to Q1 2023.
- Evome Medical Technologies Inc. Deferred Income Tax Expense (Benefit) for the quarter ending March 31, 2023 was CA$0.000.
- Evome Medical Technologies Inc. Deferred Income Tax Expense (Benefit) for the twelve months ending March 31, 2023 was -CA$193K, a 68.9% decline year-over-year.
- Evome Medical Technologies Inc. annual Deferred Income Tax Expense (Benefit) for 2023 was CA$0.000.
- Evome Medical Technologies Inc. annual Deferred Income Tax Expense (Benefit) for 2021 was -CA$114K.
Deferred Income Tax Expense (Benefit), Trailing 12 Months (CAD)
Deferred Income Tax Expense (Benefit), Quarterly (CAD)